Therapeutic prostate cancer interventions: a systematic review on pubic arch interference and needle positioning errors

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca A Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. doi:10.3322/caac.21763
   PubMed Web of Science ®Google Scholar
• Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012;367(3):203–213. doi: 10.1056/NEJMoa1113162
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zhang J, Liu Y, et al. Efficacy and toxicity of external-beam radiation therapy for localised prostate cancer: a network meta-analysis. Br J Cancer. 2014;110(10):2396–2404. doi:10.1038/bjc.2014.197
   PubMed Web of Science ®Google Scholar
• Martin JM, Handorf EA, Kutikov A, et al. The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the national cancer data base. Cancer. 2014;120(14):2114–2121. doi: 10.1002/cncr.28697
   PubMed Web of Science ®Google Scholar
• Jain A, Deguet A, Iordachita I, et al. Intra-operative 3D guidance and edema detection in prostate brachytherapy using a non-isocentric C-arm. Med Image Anal. 2012;16(3):731–743. doi: 10.1016/j.media.2010.07.011
   PubMed Web of Science ®Google Scholar
• Frank SJ, Pisters LL, Davis J, et al. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol. 2007;177(6):2151–2156. doi:10.1016/j.juro.2007.01.134
   PubMed Web of Science ®Google Scholar
• Lodeizen O, de Bruin M, Eggener S, et al. Ablation energies for focal treatment of prostate cancer. World J Urol. 2019;37(3):409–418. doi: 10.1007/s00345-018-2364-x
   PubMed Web of Science ®Google Scholar
• De La Rosette J, Ahmed H, Barentsz J, et al. Focal therapy in prostate cancer—report from a consensus panel. Jf Endourol. 2010;24(5):775–780. doi: 10.1089/end.2009.0596
   PubMed Web of Science ®Google Scholar
• Tincher SA, Kim RY, Ezekiel MP, et al. Effects of pelvic rotation and needle angle on pubic arch interference during transperineal prostate implants. Int J Radiat Oncol Biol Phys. 2000;47(2):361–363. doi: 10.1016/S0360-3016(00)00434-X
   PubMed Web of Science ®Google Scholar
• Mate TP, Gottesman JE, Hatton J, et al. High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report. Int J Radiat Oncol Biol Phys. 1998;41(3):525–533. doi: 10.1016/S0360-3016(98)00097-2
   PubMed Web of Science ®Google Scholar
• Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3(1):1–13. doi: 10.1186/1471-2288-3-25
   PubMedGoogle Scholar
• D’Souza D, Baldassarre F, Morton G, et al. Imaging technologies for high dose rate brachytherapy for cervical cancer: a systematic review. Clin Oncol. 2011;23(7):460–475. doi:10.1016/j.clon.2011.02.014
   Web of Science ®Google Scholar
• Jamema SV, Saju S, Shetty UM, et al. Dosimetric comparison of inverse optimization with geometric optimization in combination with graphical optimization for HDR prostate implants. J Med Phys/Assoc Med Physicists India. 2006;31(2):89. doi: 10.4103/0971-6203.26694
   Google Scholar
• Taschereau R, Pouliot J, Roy J, et al. Seed misplacement and stabilizing needles in transperineal permanent prostate implants. Radiother Oncol. 2000;55(1):59–63. doi: 10.1016/S0167-8140(00)00162-6
   PubMed Web of Science ®Google Scholar
• de Vries M, Wilby S, Palmer AL, et al. Overcoming pubic arch interference in prostate brachytherapy using steerable needles. J Contemp Brachytherapy. 2022;14(5):495–500. doi: 10.5114/jcb.2022.121562
   PubMed Web of Science ®Google Scholar
• Zheng Y, Wu J, Chen S, et al. Predicting pubic arch interference in permanent prostate brachytherapy based on the specific parameters derived from nuclear magnetic resonance imaging. J Contemp Brachytherapy. 2018;10(5):405–410. doi: 10.5114/jcb.2018.79247
   PubMed Web of Science ®Google Scholar
• Martin GV, Pugh TJ, Mahmood U, et al. Permanent prostate brachytherapy pubic arch evaluation with diagnostic magnetic resonance imaging. Brachytherapy. 2017;16(4):728–733. doi: 10.1016/j.brachy.2017.02.001
   PubMed Web of Science ®Google Scholar
• Fukada J, Shigematsu N, Nakashima J, et al. Predicting pubic arch interference in prostate brachytherapy on transrectal ultrasonography-computed tomography fusion images. J Radiat Res. 2012;53(5):753–759. doi: 10.1093/jrr/rrs020
   PubMed Web of Science ®Google Scholar
• Ryu B, Bax J, Edirisinge C, et al. Prostate brachytherapy with oblique needles to treat large glands and overcome pubic arch interference. Int J Radiat Oncol Biol Phys. 2012;83:1463–1472. doi: 10.1016/j.ijrobp.2011.10.012
   PubMed Web of Science ®Google Scholar
• Gibbons EP, Smith RP, Beriwal S, et al. Overcoming pubic arch interference with free-hand needle placement in men undergoing prostate brachytherapy. Brachytherapy. 2009;8(1):74–78. doi: 10.1016/j.brachy.2008.04.007
   PubMed Web of Science ®Google Scholar
• Sejpal SV, Sathiaseelan V, Helenowski IB, et al. Intra-operative pubic arch interference during prostate seed brachytherapy in patients with CT-based pubic arch interference of ≤1 cm. Radiother Oncol. 2009;91(2):249–254. doi: 10.1016/j.radonc.2009.02.006
   PubMed Web of Science ®Google Scholar
• Nickers P, Thissen B, Jansen N, et al. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view. Radiother Oncol. 2006;78(1):47–52. doi: 10.1016/j.radonc.2005.09.002
   PubMed Web of Science ®Google Scholar
• Henderson A, Laing RW, Langley SEM. Identification of pubic arch interference in prostate brachytherapy: simplifying the transrectal ultrasound technique. Brachytherapy. 2003;2(4):240–245. doi: 10.1016/j.brachy.2003.11.001
   PubMedGoogle Scholar
• Strang JG, Rubens DJ, Brasacchio RA, et al. Real-time US versus CT determination of pubic arch interference for brachytherapy. Radiology. 2001;219(2):387–393. doi: 10.1148/radiology.219.2.r01ma37387
   PubMed Web of Science ®Google Scholar
• Wang H, Wallner K, Sutlief S, et al. Transperineal brachytherapy in patients with large prostate glands. Int J Cancer. 2000;90(4):199–205. doi: 10.1002/1097-0215(20000820)90:4<199:AID-IJC3>3.0.CO;2-C
   PubMed Web of Science ®Google Scholar
• Bellon J, Wallner K, Ellis W, et al. Use of pelvic CT scanning to evaluate pubic arch interference of transperineal prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1999;43(3):579–581. doi: 10.1016/S0360-3016(98)00466-0
   PubMed Web of Science ®Google Scholar
• Wallner K, Ellis W, Russell K, et al. Use of TRUS to predict pubic arch interference of prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1999;43:583–585. doi: 10.1016/S0360-3016(98)00459-3
   PubMed Web of Science ®Google Scholar
• Borghede G, Hedelin H, Holmäng S, et al. Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland. Radiother Oncol. 1997;44:245–250. doi: 10.1016/S0167-8140(97)00122-9
   PubMed Web of Science ®Google Scholar
• Jamaluddin MF, Ghosh S, Waine MP, et al. Quantifying 125I placement accuracy in prostate brachytherapy using postimplant transrectal ultrasound images. Brachytherapy. 2017;16(2):306–312. doi: 10.1016/j.brachy.2016.11.015
   PubMed Web of Science ®Google Scholar
• Cepek J, Lindner U, Ghai S, et al. Mechatronic system for in-bore MRI-guided insertion of needles to the prostate: an in vivo needle guidance accuracy study. J Magn Reson Imaging. 2015;42(1):48–55. doi: 10.1002/jmri.24742
   PubMed Web of Science ®Google Scholar
• Fichtinger G, Fiene JP, Kennedy CW, et al. Robotic assistance for ultrasound-guided prostate brachytherapy. Med Image Anal. 2008;12:535–545. doi: 10.1016/j.media.2008.06.002
   PubMed Web of Science ®Google Scholar
• Szlag M, Ślosarek K, Rembielak A, et al. Real-time brachytherapy for prostate cancer – implant analysis. Rep Pract Oncol Radiother. 2008;13(1):9–14. doi: 10.1016/S1507-1367(10)60076-4
   Google Scholar
• Cormack RA, Tempany CM, D’Amico AV. Optimizing target coverage by dosimetric feedback during prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2000;48(4):1245–1249. doi: 10.1016/S0360-3016(00)00742-2
   PubMed Web of Science ®Google Scholar
• Huang Y, Miller B, Doemer A, et al. Online correction of catheter movement using CT in high-dose-rate prostate brachytherapy. Brachytherapy. 2013;12(3):260–266. doi: 10.1016/j.brachy.2012.08.008
   PubMed Web of Science ®Google Scholar
• Whitaker M, Hruby G, Lovett A, et al. Prostate HDR brachytherapy catheter displacement between planning and treatment delivery. Radiother Oncol. 2011;101:490–494. doi: 10.1016/j.radonc.2011.08.004
   PubMed Web of Science ®Google Scholar
• Holly R, Morton GC, Sankreacha R, et al. Use of cone-beam imaging to correct for catheter displacement in high dose-rate prostate brachytherapy. Brachytherapy. 2011;10(4):299–305. doi: 10.1016/j.brachy.2010.11.007
   PubMed Web of Science ®Google Scholar
• Kovalchuk N, Furutani KM, MacDonald OK, et al. Dosimetric effect of interfractional needle displacement in prostate high-dose-rate brachytherapy. Brachytherapy. 2012;11(2):111–118. doi: 10.1016/j.brachy.2011.05.006
   PubMed Web of Science ®Google Scholar
• Reynés-Llompart G, Pino F, Modolell I, et al. Impact of prostate catheter displacement in inverse planning–simulated annealing and geometric optimization. Brachytherapy. 2016;15(1):112–117. doi: 10.1016/j.brachy.2015.10.003
   PubMed Web of Science ®Google Scholar
• Carrara M, Tenconi C, Mazzeo D, et al. Study of the correlation between rectal wall in vivo dosimetry performed with MOSkins and implant modification during TRUS-guided HDR prostate brachytherapy. Radiat Meas. 2017;106:385–390. doi: 10.1016/j.radmeas.2017.03.016
   Web of Science ®Google Scholar
• Buus S, Lizondo M, Hokland S, et al. Needle migration and dosimetric impact in high-dose-rate brachytherapy for prostate cancer evaluated by repeated MRI. Brachytherapy. 2018;17(1):50–58. doi: 10.1016/j.brachy.2017.08.005
   PubMed Web of Science ®Google Scholar
• Mullokandov E, Gejerman G. Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy. Int J Radiat Oncol Biol Phys. 2004;58(4):1063–1071. doi: 10.1016/j.ijrobp.2003.08.020
   PubMed Web of Science ®Google Scholar
• Damore SJ, Syed AMN, Puthawala AA, et al. Needle displacement during HDR brachytherapy in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2000;46(5):1205–1211. doi: 10.1016/S0360-3016(99)00477-0
   PubMed Web of Science ®Google Scholar
• Pellizzon ACA, Salvajoli JV, Novaes PERS, et al. Needle displacement during high-dose-rate afterloading brachytherapy boost and conventional external beam radiation therapy for initial and local advanced prostate cancer. Urol Int. 2003;70(3):200–204. doi: 10.1159/000068775
   PubMed Web of Science ®Google Scholar
• Smith RL, Hanlon M, Panettieri V, et al. An integrated system for clinical treatment verification of HDR prostate brachytherapy combining source tracking with pretreatment imaging. Brachytherapy. 2018;17(1):111–121. doi: 10.1016/j.brachy.2017.08.004
   PubMed Web of Science ®Google Scholar
• Martinez AA, Pataki I, Edmundson G, et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report. Int J Radiat Oncol Biol Phys. 2001;49(1):61–69. doi: 10.1016/S0360-3016(00)01463-2
   PubMed Web of Science ®Google Scholar
• Pieters BR, van der Grient JNB, Blank LECM, et al. Minimal displacement of novel self-anchoring catheters suitable for temporary prostate implants. Radiother Oncol. 2006;80(1):69–72. doi: 10.1016/j.radonc.2006.06.014
   PubMed Web of Science ®Google Scholar
• Fox CD, Kron T, Leahy M, et al. Interfraction patient motion and implant displacement in prostate high dose rate brachytherapy. Med Phys. 2011;38(11):5838–5843. doi: 10.1118/1.3641865
   PubMed Web of Science ®Google Scholar
• Hoskin PJ, Bownes PJ, Ostler P, et al. High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. Radiother Oncol. 2003;68(3):285–288. doi: 10.1016/S0167-8140(03)00203-2
   PubMed Web of Science ®Google Scholar
• Maenhout M, van der Voort van Zyp JRN, Borot de Battisti M, et al. The effect of catheter displacement and anatomical variations on the dose distribution in MRI-guided focal HDR brachytherapy for prostate cancer. Brachytherapy. 2018;17(1):24–30. doi: 10.1016/j.brachy.2017.04.239
   PubMed Web of Science ®Google Scholar
• Dickhoff LR, Kerkhof EM, Deuzeman HH, et al. Adaptive objective configuration in bi-objective evolutionary optimization for cervical cancer brachytherapy treatment planning. Proceedings of the Genetic and Evolutionary Computation Conference; 2022;1173–1181.
   Google Scholar
• Davis BJ, Horwitz EM, Lee WR, et al. American brachytherapy society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy. Brachytherapy. 2012;11(1):6–19. doi: 10.1016/j.brachy.2011.07.005
   PubMed Web of Science ®Google Scholar
• Henry A, Pieters BR, Siebert FA, et al. GEC-ESTRO ACROP prostate brachytherapy guidelines. Radiother Oncol. 2022;167:244–251. doi:10.1016/j.radonc.2021.12.047
   PubMed Web of Science ®Google Scholar
• van Gerwen DJ, Dankelman J, van den Dobbelsteen JJ. Needle–tissue interaction forces–a survey of experimental data. Med Eng & Phys. 2012;34(6):665–680. doi: 10.1016/j.medengphy.2012.04.007
   PubMed Web of Science ®Google Scholar
• Misra S, Reed KB, Douglas AS, et al. Needle-tissue interaction forces for bevel-tip steerable needles. In: 2008 2nd IEEE RAS & EMBS International Conference on Biomedical Robotics and Biomechatronics; Scottsdale, AZ, USA. IEEE; 2008. p. 224–231.
   Google Scholar
• Wan G, Wei Z, Gardi L, et al. Brachytherapy needle deflection evaluation and correction. Med Phys. 2005;32:902–909. doi: 10.1118/1.1871372
   PubMed Web of Science ®Google Scholar
• Aluwini S, Busser WMH, Baartman LEA, et al. Fractionated high-dose-rate brachytherapy as monotherapy in prostate cancer: does implant displacement and its correction influence acute and late toxicity? Brachytherapy. 2016;15(6):707–713. doi: 10.1016/j.brachy.2016.05.008
   PubMed Web of Science ®Google Scholar
• Tiong A, Bydder S, Ebert M, et al. A small tolerance for catheter displacement in high–dose rate prostate brachytherapy is necessary and feasible. Int J Radiat Oncol Biol Phys. 2010;76(4):1066–1072. doi: 10.1016/j.ijrobp.2009.03.052
   PubMed Web of Science ®Google Scholar
• Kolkman-Deurloo IKK, Roos MA, Aluwini S. HDR monotherapy for prostate cancer: a simulation study to determine the effect of catheter displacement on target coverage and normal tissue irradiation. Radiother Oncol. 2011;98:192–197. doi: 10.1016/j.radonc.2010.12.009
   PubMed Web of Science ®Google Scholar
• Poder J, Carrara M, Howie A, et al. Derivation of in vivo source tracking error thresholds for TRUS-based HDR prostate brachytherapy through simulation of source positioning errors. Brachytherapy. 2019;18(5):711–719. doi: 10.1016/j.brachy.2019.05.001
   PubMed Web of Science ®Google Scholar
• Mason J, Henry A, Bownes P. Error detection thresholds for routine real time in vivo dosimetry in HDR prostate brachytherapy. Radiother Oncol. 2020;149:38–43. doi:10.1016/j.radonc.2020.04.058
   PubMed Web of Science ®Google Scholar
• Takenaka T, Yoshida K, Ueda M, et al. Assessment of daily needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer using daily CT examinations. J RAD Res. 2012;53:469–474. doi: 10.1269/jrr.11168
   PubMed Web of Science ®Google Scholar
• Simnor T, Li S, Lowe G, et al. Justification for inter-fraction correction of catheter movement in fractionated high dose-rate brachytherapy treatment of prostate cancer. Radiother Oncol. 2009;93(2):253–258. doi: 10.1016/j.radonc.2009.09.015
   PubMed Web of Science ®Google Scholar
• Yamoah K, Eldredge-Hindy HB, Zaorsky NG, et al. Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma. Brachytherapy. 2014;13(5):456–464. doi: 10.1016/j.brachy.2014.04.003
   PubMed Web of Science ®Google Scholar
• Kim Y, Hsu IC, Lessard E, et al. Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions. Int J Radiat Oncol Biol Phys. 2004;59(4):1208–1216. doi: 10.1016/j.ijrobp.2004.02.053
   PubMed Web of Science ®Google Scholar
• Ballester MAG, Zisserman AP, Brady M. Estimation of the partial volume effect in MRI. Med Image Anal. 2002;6(4):389–405. doi: 10.1016/S1361-8415(02)00061-0
   PubMed Web of Science ®Google Scholar
• Fedorov A, Khallaghi S, Sánchez CA, et al. Open-source image registration for MRI–TRUS fusion-guided prostate interventions. Int J Comput Assist Radiol Surg. 2015;10(6):925–934. doi: 10.1007/s11548-015-1180-7
   PubMed Web of Science ®Google Scholar
• Klotz CL. Can high resolution micro-ultrasound replace MRI in the diagnosis of prostate cancer? Eur Urol Focus. 2020;6(2):419–423. doi: 10.1016/j.euf.2019.11.006
   PubMedGoogle Scholar
• Kim Y, Hsu IC, Pouliot J. Measurement of craniocaudal catheter displacement between fractions in computed tomography–based high dose rate brachytherapy of prostate cancer. J Appl Clin Med Phys. 2007;8(4):1–13. doi: 10.1120/jacmp.v8i4.2415
   PubMed Web of Science ®Google Scholar
• Kucway R, Vicini F, Huang R, et al. Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy. J Urol. 2002;167(6):2443–2447. doi: 10.1016/S0022-5347(05)65001-X
   PubMed Web of Science ®Google Scholar
• Press RH, Morgan TM, Cutrell PK, et al. Patient-reported health-related quality of life outcomes after HDR brachytherapy between small (<60 cc) and large (≥60 cc) prostate glands. Brachytherapy. 2019;18:13–21. doi: 10.1016/j.brachy.2018.08.009
   PubMed Web of Science ®Google Scholar
• Kopp RP, Marshall LM, Wang PY, et al. The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors. Eur Urol. 2013;64(4):672–679. doi: 10.1016/j.eururo.2013.03.041
   PubMed Web of Science ®Google Scholar
• Saigal CS, Gore JL, Krupski TL, et al. Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer: Interdiscip Int J Am Cancer Soc. 2007;110(7):1493–1500. doi:10.1002/cncr.22933
   Google Scholar
• Basaria S, Lieb J, Tang AM, et al. Long‐term effects of androgen deprivation therapy in prostate cancer patients. Clinical Endocrinol. 2002;56(6):779–786. doi: 10.1046/j.1365-2265.2002.01551.x
   PubMed Web of Science ®Google Scholar
• Keyes M, Merrick G, Frank SJ, et al. Use of androgen deprivation therapy with prostate brachytherapy, a systematic literature review. Brachytherapy. 2017;16(2):245. doi: 10.1016/j.brachy.2016.11.017
   PubMed Web of Science ®Google Scholar
• Karius A, Strnad V, Lotter M, et al. First clinical experience with a novel, mobile cone-beam CT system for treatment quality assurance in brachytherapy. Strahlenther Onkol. 2022;198(6):573–581. doi: 10.1007/s00066-022-01912-7
   PubMed Web of Science ®Google Scholar
• Karius A, Karolczak M, Strnad V, et al. Technical evaluation of the cone‐beam computed tomography imaging performance of a novel, mobile, gantry‐based X‐ray system for brachytherapy. J Appl Clin Med Phys. 2022;23(2):e13501. doi: 10.1002/acm2.13501
   PubMed Web of Science ®Google Scholar
• Chernavsky NE, Morcos M, Wu P, et al. Technical assessment of a mobile CT scanner for image‐guided brachytherapy. J Appl Clin Med Phys. 2019;20(10):187–200. doi: 10.1002/acm2.12738
   PubMed Web of Science ®Google Scholar
• Stone NN, Stock RG. Prostate brachytherapy in patients with prostate volumes ≥ 50 cm3: dosimetic analysis of implant quality. Int J Radiat Oncol Biol Phys. 2000;46:1199–1204. doi: 10.1016/S0360-3016(99)00516-7
   PubMed Web of Science ®Google Scholar
• Roy JN, Wallner KE, Chiu-Tsao ST, et al. CT-based optimized planning for transperineal prostate implant with customized template. Int J Radiat Oncol Biol Phys. 1991;21(2):483–489. doi: 10.1016/0360-3016(91)90800-J
   PubMed Web of Science ®Google Scholar
• Kettenbach J, Kronreif G. Robotic systems for percutaneous needle-guided interventions. Minimally Invasive Ther Allied Technol. 2015;24(1):45–53. doi:10.3109/13645706.2014.977299
   PubMed Web of Science ®Google Scholar
• van de Berg NJ, Dankelman J, van den Dobbelsteen JJ. Design of an actively controlled steerable needle with tendon actuation and FBG-based shape sensing. Med Eng Phys. 2015;37(6):617–622. doi: 10.1016/j.medengphy.2015.03.016
   PubMed Web of Science ®Google Scholar
• de Vries M, Sikorski J, Misra S, et al. Axially rigid steerable needle with compliant active tip control. PLOS ONE. 2021;16(12):e0261089. doi:10.1371/journal.pone.0261089
   PubMed Web of Science ®Google Scholar
• Podder TK, Dicker AP, Hutapea P, et al. A novel curvilinear approach for prostate seed implantation. Med Phys. 2012;39(4):1887–1892. doi: 10.1118/1.3694110
   PubMed Web of Science ®Google Scholar
• Bloemberg J, Trauzettel F, Coolen B, et al. Design and evaluation of an MRI-ready, self-propelled needle for prostate interventions. PLOS ONE. 2022;17(9):e0274063. doi:10.1371/journal.pone.0274063
   PubMed Web of Science ®Google Scholar
• Marcu LG, Lawson JM. Technical and dosimetric aspects of iodine-125 seed reimplantation in suboptimal prostate implants. Br J Radiol. 2013;86(1026):20130058. doi: 10.1259/bjr.20130058
   PubMed Web of Science ®Google Scholar
• Keyes M, Pickles T, Agranovich A, et al. 125I reimplantation in patients with poor initial dosimetry after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2004;60(1):40–50. doi: 10.1016/j.ijrobp.2004.02.011
   PubMed Web of Science ®Google Scholar
• Hughes L, Waterman FM, Dicker AP. Salvage of suboptimal prostate seed implantation: reimplantation of underdosed region of prostate base. Brachytherapy. 2005;4(2):163–170. doi: 10.1016/j.brachy.2005.03.002
   PubMedGoogle Scholar
• Morris WJ, Spadinger I, Keyes M, et al. Whole prostate D90 and V100: a dose–response analysis of 2000 consecutive 125I monotherapy patients. Brachytherapy. 2014;13(1):32–41. doi: 10.1016/j.brachy.2013.08.006
   PubMed Web of Science ®Google Scholar
• Natarajan S, Raman S, Priester AM, et al. Focal laser ablation of prostate cancer: phase I clinical trial. J Urol. 2016;196:68–75. doi: 10.1016/j.juro.2015.12.083
   PubMed Web of Science ®Google Scholar
• Skowronek J. Current status of brachytherapy in cancer treatment–short overview. J Contemp Brachytherapy. 2017;9(6):581–589. doi: 10.5114/jcb.2017.72607
   PubMed Web of Science ®Google Scholar
• Devlin PM, Holloway CL, Stewart AJ. Brachytherapy: applications and techniques. New York: Springer Publishing Company; 2015.
   Google Scholar
• Fischer GS, Iordachita I, Csoma C, et al. MRI-compatible pneumatic robot for transperineal prostate needle placement. IEEE/ASME Trans Mechatron. 2008;13(3):295–305. doi: 10.1109/TMECH.2008.924044
   PubMed Web of Science ®Google Scholar
• Siepel FJ, Maris B, Welleweerd MK, et al. Needle and biopsy robots: a review. Curr Robot Rep. 2021;2(1):73–84. doi: 10.1007/s43154-020-00042-1
   Google Scholar
• David A, Brennan V, Cohen G, et al. Is there a clinically meaningful change in anatomy during planning of US HDR prostate brachytherapy? Radiother Oncol. 2019;133:S586. doi: 10.1016/S0167-8140(19)31472-0
   Web of Science ®Google Scholar
• Wu CHD, Thind K, Husain S, et al. 63 prostate and catheter motion in prostate HDR brachytherapy: from operating room to shielded delivery vault. Radiother Oncol. 2019;139:S29. doi:10.1016/S0167-8140(19)33352-3
   Web of Science ®Google Scholar
• Peddada AV, Blasi OC, White GA, et al. Prevention of needle displacement in multifraction high-dose-rate prostate brachytherapy: a prospective volumetric analysis and technical considerations. Pract Radiat Oncol. 2015;5:228–237. doi: 10.1016/j.prro.2014.11.004
   PubMedGoogle Scholar
• Dinkla AM, Pieters BR, Koedooder K, et al. Prostate volume and implant configuration during 48 hours of temporary prostate brachytherapy: limited effect of oedema. Radiat Oncol. 2014;9. doi: 10.1186/s13014-014-0272-9
   PubMed Web of Science ®Google Scholar
• Kawakami S, Ishiyama H, Terazaki T, et al. Catheter displacement prior to the delivery of high-dose-rate brachytherapy in the treatment of prostate cancer patients. J Contemp Brachytherapy. 2014;6:161–166. doi: 10.5114/jcb.2014.43619
   PubMed Web of Science ®Google Scholar
• Foster W, Cunha JAM, Hsu IC, et al. Dosimetric impact of interfraction catheter movement in high-dose rate prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2011;80:85–90. doi: 10.1016/j.ijrobp.2010.01.016
   PubMed Web of Science ®Google Scholar
• Milickovic N, Mavroidis P, Tselis N, et al. 4D analysis of influence of patient movement and anatomy alteration on the quality of 3D U/S-based prostate HDR brachytherapy treatment delivery. Med Phys. 2011;38(9):4982–4993. doi: 10.1118/1.3618735
   PubMed Web of Science ®Google Scholar
• Yoshida K, Yamazaki H, Nose T, et al. Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer. Brachytherapy. 2010;9(1):36–41. doi: 10.1016/j.brachy.2009.04.006
   PubMed Web of Science ®Google Scholar